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Objective: Persistent right umbilical vein (PRUV) is a vascular anomaly where the right umbilical vein
remains as the only conduit that returns oxygenated blood to the fetus. It has classically been described
as associated with numerous defects. We distinguish the intrahepatic variant (better prognosis) and the
extrahepatic variant (associated with worse prognosis). The objective of this study was to compare rates
of congenital malformations in fetuses with intrahepatic PRUV (I-PRUV) versus singleton pregnancies
without risk factors.
Materials and Methods: A multicenter, crossover design, comparative study was performed between
2003 and 2013 on fetuses diagnosed with I-PRUV (n¼ 56), and singleton pregnancies without congenital
malformation risk factors (n¼ 4050).
Results: Fifty-six cases of I-PRUV were diagnosed (incidence 1:770). A statistically significant association
between I-PRUV and the presence of congenital malformations (odds ratio 4.321; 95% confidence interval
2.15e8.69) was found. This positive association was only observed with genitourinary malformations
(odds ratio 3.038; 95% confidence interval 1.08e8.56).
Conclusion: Our rate of malformations associated with I-PRUV (17.9%) is similar to previously published
rates. I-PRUV has shown a significant increase in the rate of associated malformations, although this
association has only been found to be statistically significant in the genitourinary system. Noteworthy is
the fact that this comparative study has not pointed to a significant increase in the congenital heart
malformation rate. Diagnosis of isolated I-PRUV does not carry a worse prognosis.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Persistent right umbilical vein (PRUV) is a vascular anomaly that
involves the obliteration of the left umbilical vein, leaving the right
umbilical vein as the only conduit that returns oxygenated blood
from the placenta. Two variants are described: intrahepatic (I-
PRUV), with proper development of ductus venosus; andia y Ginecología, Hospital
009 Zaragoza, Spain.
go-Calvo).
bstetrics & Gynecology. Publishedextrahepatic, in which the umbilical vein drains directly into the
inferior vena cava or right atrium [1].
The first set of cases, published by Jeanty [2] in 1990, presented a
rate of associated malformations of 50%, most of them being
congenital heart diseases. Therefore, this entity has traditionally
been considered a rare anomaly associated with poor prognosis.
Recent studies report a better prognosis [3e5], but rates of asso-
ciated malformations in the latest series show extremely dissimilar
results, between 8% and 40.9% [3,6].
I-PRUV is one of the most common fetal venous anomalies, with
an estimated incidence varying from 1:250 to 1:1000 pregnancies
[2e11]. This study was designed to compare malformations’ rate ofby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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risk factors for associated congenital anomalies.
Material and methods
Data were collected from the pregnant patients with fetal ul-
trasound diagnosis of I-PRUV from two tertiary centers: Hospital
Universitario Puerta de Hierro, Madrid, Spain (since 2003) and
Hospital Universitario Miguel Servet, Zaragoza, Spain (from 2007 to
May 2013).
First-trimester combined tests for early screening of chromo-
somal abnormalities was carried out in all patients. Inclusion
criteria for cases were: fetus with ultrasound diagnosis of I-PRUV;
singleton pregnancy, obstetric referral hospital control, and
execution of at least three ultrasound scans (1st, 2nd, and 3rd tri-
mesters). Cases whose data collection could not be completed were
excluded. We used the criteria described by Jeanty [4] to diagnose
this entity. A case of prenatal diagnosis of I-PRUV is shown in
Figure 1.
Patients with singleton pregnancies, whose pregnancies were
controlled at Hospital Universitario Miguel Servet in Zaragoza be-
tween January 1, 2011 and December 31, 2013, were recruited
consecutively for the control group. Those who met the following
criteria were excluded: smoking mother; incomplete prenatal
screening; maternal congenital malformation; gestational dia-
betes; maternal conditions that may be associated with congenital
malformations such as diabetes, obesity, bariatric surgery, auto-
immune disease, hematologic disease, neoplasia, neurological, or
psychiatric illness on drug therapy; and documented use of other
drugs with teratogenic potential (U.S. Food and Drug Administra-
tion category X). After applying these inclusion and exclusion
criteria, a database was obtained for the control group of 4050
pregnancies, without risk factor for congenital anomalies.
For the statistical analysis, firstly all the variables analyzed
were described, and then a bivariate analysis was conducted,
comparing both groups. The variables were described using per-
centages. In the bivariate analysis, an analysis of contingency ta-
bles with odds ratio (OR) calculation was performed, using SPSSFigure 1. Ultrasound prenatal diagnosis of persistent right umbiliStatistics for Mac OsX. 1999. V19.0. Chicago: IBM. The confidence
interval (CI) used was 95%.
Results
During the study period, 43,149 pregnancies were examined, of
which 56 fetuses with I-PRUV were identified, corresponding to an
incidence rate of 1:770.
The proportion of cases founded was almost identical in both
hospitals, 51.8% and 48.2% respectively.
The profile of mothers corresponded in 55.4% of cases to
nulliparous women with a mean age of 31.83± 4.29 years. The
majority of fetuses weremale (62.5%), with amale to female ratio of
1.66:1. I-PRUV fetuses were diagnosed between Weeks 19þ0 and
35þ2 of gestation (mean gestational age, 20þ1 weeks).
Of fetuses with I-PRUV, 82.1% showed no associated malfor-
mation. In the 10 cases with associated malformations (17.9%) the
most frequent were genitourinary (7.1%) and vascular abnormal-
ities of the umbilical cord (3.6%).
Furthermore, 17.9% of I-PRUV fetuses underwent karyotyping,
showing no abnormality. The antenatal survey was also completed
by echocardiography in 19.6% of cases, diagnosing a ventricular
septal defect (as displayed in mid trimester ultrasound) and an
aberrant right subclavian artery (Table 1).
The malformation rate presented by I-PRUV cases was
compared with the group of 4050 risk factor-free pregnancies.
When we classified these malformations into systems, we noted
that the proportion of genitourinary system’s malformations was
4.67 points higher in fetuses with I-PRUV regarding to those
without I-PRUV, followed by umbilical cord (2.34 points), skeletal
system (1.49 points) and heart (1.3 points) malformations.
A positive association between the presence of I-PRUV and the
presence of any congenital malformations (OR, 4.321; 95%CI,
2.15e8.69)] was found. Malformations of the genitourinary system
were the only ones that showed this positive association (OR 3.038;
95%CI 1.08e8.56). We did not observe significant association when
congenital heart defects, skeletal, and umbilical cord malforma-
tions were compared. No malformation of the central nervouscal vein. GB¼ gallbladder; S¼ stomach; UV¼ umbilical vein.
Table 1
Malformations associated with persistent right umbilical vein.
Associated malformation Yes 10 (17.9 %)
No 46 (82.1 %)
Malformations Umbilical cord SUA (2) 2 (3.6 %)
Heart VSD (1) 1 (1.8 %)




Genetic syndromes Microretrognathia, camptodactyly (1) 1 (1.8 %)
Others Congenital stenosis of lachrymal duct (1) Aberrant right subclavian artery (1) 2 (3.6 %)
Karyotype Not performed 46 (82.1 %)
Performed (Normal) 10 (17.9 %)
Echocardiography Not performed 45 (80.3 %)
Performed: no findings 9 (16.1 %)
Performed: findings of CHD 2 (3.6 %)
CHD¼ congenital heart disease; SUA¼ single umbilical artery; VSD¼ ventricular septal defect.
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calculated (Table 2).
Discussion
Although there are many publications on I-PRUV, solely
descriptive studies are carried out in all of them, and preferably of
associated congenital malformations. Our work, by contrast, is the
first analytical study, that we are aware of, where rates of
congenital anomalies, both overall and by systems, are compared
between fetuses with I-PRUV and singleton pregnancies free from
congenital anomaly risk factors.
In the 56 cases of I-PRUV included in our study, we observed 10
cases of associated congenital malformations, equal to a percentage
of 17.9%, which is close to the midpoint of data published by other
authors (8e40.9%) [2,3,6,11]. Remarkable is the fact that the rate of
associated congenital malformations in the control population
(4.79%) is similar to those reported previously [12], asserting that
both major and minor congenital anomalies are included therein.
The discrepancy in the published rates, mostly during the 1990s
and early 2000s, could be explained, firstly, by the improved quality
of ultrasound machines and, secondly, by the establishment of
aneuploidy screening in the first trimester, over the last few years.
This allowed the earlier detection of cases of more common chro-
mosomal abnormalities and major malformations that could
associate an I-PRUV, from which a high percentage end up in
abortion.
After performing a comparative study between the group of
cases and controls, I-PRUV has statistically proven to be a risk factor
for the presence of other associated congenital malformations, inTable 2
Relationship between malformations (by systems) among fetuses with intrahepatic pers
Cases
n (%)
Malformations Yes 10 (17.86)
No 46 (82.14)
Umbilical cord Yes 2 (3.57)
No 54 (96.43)
Heart Yes 1 (1.79)
No 55 (98.21)
Genitourinary Yes 4 (7.14)
No 52 (92.86)
Skeletal Yes 1 (1.79)
No 55 (98.21)
Central nervous system Yes 0 (0.0)
No 56 (100)
CI¼ confidence interval; OR¼ odds ratio.particular, in the genitourinary system. Note that the umbilical cord
malformations, if isolated and associated with normal intrauterine
growth, will have no impact on postnatal life. No significant dif-
ferences were found in birth defects relating to congenital heart
defects, umbilical cord, skeletal, or nervous systems.
The rate of cardiac malformations showed no statistical differ-
ences between I-PRUV and control cases. In addition, the propor-
tion of associated cardiac anomalies (1.8%) is substantially lower
than previously published (11.5%). Many congenital cardiac mal-
formations, when associated with chromosomal abnormalities and
diagnosed in the first trimester, could have led mothers to opt for a
legal abortion, so this rate, whichwould potentially be detectable in
morphological ultrasound, would be reduced. However, we are not
a national reference center for this type of pathology. Many of the
studies on PRUV [2,6] were conducted in reference centers for the
study of heart diseases, and the relative frequency of these mal-
formations is increased in their target population. Although we are
aware that sensitivity in the diagnosis of cardiac abnormalities is
not 100%, our rate of cardiac malformations (0.5%) in the control
group is consistent with that reported by other tertiary centerswith
a similar target population to ours [13,14]. Furthermore, there are
entities that are classically considered as cardiac anomalies, such as
echogenic intracardiac foci, which, over the years, are no longer
considered as such, and are treated today as benign entities.
No additional tests (echocardiography or fetal karyotype) were
systematically performed, backed up by the good prognosis
described by the new published data [15], as well as by the
centralized execution of all the scans of our health areas by expe-
rienced sonographers who performed in all the scans the Yagel [16]
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yotype, and so we have only performed 21 additional tests: 11
echocardiographic studies and 10 fetal karyotypes.
Alterations were found in two of the 11 echocardiographic
studies performed.
One case of ventricular septal defect was diagnosed, as
described in the midtrimester scan, and in another case aberrant
right subclavian artery was diagnosed; this entity did not present
any postnatal complication.
In view of our results, which have shown a significantly higher
rate of associated malformations, we recommend conducting a
comprehensive morphological study on fetuses that present I-
PRUV to rule out other associated malformations, paying particular
interest to umbilical cord vascularization and genitourinary
morphology. By contrast, we cannot recommend the presence of I-
PRUV as an ultrasound marker for congenital heart disease. This
contrasts with other authors [2,4] who proposed that the PRUV
should be an ultrasound marker of heart disease, recommending
the performance of fetal echocardiography when this is suspected.
Another argument for reserving fetal echocardiography for
selected cases is that in our clinical setting, the five cuts described
by Yagel [16] to detect heart diseases are routinely performed in all
morphologic ultrasound scans.
Karyotype was performed by amniocentesis on 10 fetuses with
isolated I-PRUV. No chromosomal abnormalities were observed in
any of these cases. No evidence was found either, in the postnatal
control that pointed to the need for this type of test. Because of
these results, we consider that when diagnosing isolated I-PRUV,
we must be cautious when indicating the execution of an amnio-
centesis to study fetal karyotype, as this is an invasive test with
miscarriage rates of around 0.6% [17]. Diagnosis of isolated PRUV
does not seem to carry a worse prognosis. When another malfor-
mation is associated, the outcome is given by the characteristics of
malformation associated in each case.
Conclusion
I-PRUV has shown a significant increase in the rate of associated
malformations (mainly genitourinary system); therefore, we
recommend conducting amore detailedmorphological studywhen
this entity is diagnosed.
By contrast, a significant increase in association with congenital
heart disease has not been proven. Diagnosis of isolated I-PRUV
does not carry a worse prognosis.Conflicts of interest
The authors have no conflicts of interest relevant to this article.References
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